Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1987-12-08
1989-11-28
Hollrah, Glennon H.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
5142232, 544 12, 544284, 544285, A61K 31505, C07D23980
Patent
active
048838004
ABSTRACT:
The invention relates to compounds having aldose reductase-inhibitory activity of the formula: ##STR1## in which R.sup.1 and R.sup.2 are each hydrogen, halogen, lower alkoxy or halo(lower)alkyl,
REFERENCES:
patent: 4016166 (1977-04-01), Noda et al.
patent: 4405623 (1983-09-01), Ishikawa et al.
patent: 4490374 (1984-12-01), Bandurco et al.
A. Lespagnol et al.: (I) Annales pharmaceutiques francaises, 1974, 32, No. 2, pp. 125-132.
A. Lespagnol et al.: II Eur. J. Med. Chem.-Chimica Therapeutica, May-Jun. 1974-9, No. 3, pp. 263-268.
Baba Yukihisa
Hashimoto Masashi
Ito Yoshikuni
Kasahara Chiyoshi
Namiki Takayuki
Fujisawa Pharmaceutical Co. Ltd.
Hollrah Glennon H.
Turnipseed James H.
LandOfFree
Quinazoline derivatives and process for their production does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Quinazoline derivatives and process for their production, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinazoline derivatives and process for their production will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-581940